NDC 60215-411
FludeoxyglucoseF18 300 mCi per 1 mL injection
On the label: The University of Texas MD Anderson Cancer Center.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| University of Texas MD Anderson Cancer Center | Houston, TX, United States | Makes it | Problems found, fixed voluntarilyFeb 24, 2026 · 4 inspections |
Product details
- Generic drug
- Fludeoxyglucose F-18: every company that makes it
- Form
- injection, intravenous
- Strength
- 300 mCi per 1 mL
- Approval
- ANDA ANDA203246
- On the market since
- Dec 6, 2011
- Package NDCs
60215-411-30- Official label
- DailyMed (National Library of Medicine), updated Oct 3, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?